Literature DB >> 28461373

Autologous hematopoietic cell transplantation for systemic sclerosis - a challenge for the Canadian health care system.

Jan Storek1, Andrew Daly2, Sharon A LeClercq2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28461373      PMCID： PMC5415389          DOI： 10.1503/cmaj.161346

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?

Authors:  Y Loh; Y Oyama; L Statkute; L Verda; K Quigley; K Yaung; W Barr; B Jovanovic; R K Burt
Journal:  Bone Marrow Transplant       Date:  2007-02-19       Impact factor: 5.483

2.  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Authors:  Richard A Nash; Peter A McSweeney; Leslie J Crofford; Muneer Abidi; Chien-Shing Chen; J David Godwin; Theodore A Gooley; Leona Holmberg; Gretchen Henstorf; C Fred LeMaistre; Maureen D Mayes; Kevin T McDonagh; Bernadette McLaughlin; Jerry A Molitor; J Lee Nelson; Howard Shulman; Rainer Storb; Federico Viganego; Mark H Wener; James R Seibold; Keith M Sullivan; Daniel E Furst
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

3.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

4.  Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.

Authors:  Richard A Nash; Peter A McSweeney; J Lee Nelson; Mark Wener; George E Georges; Amelia A Langston; Howard Shulman; Keith M Sullivan; Julie Lee; Gretchen Henstorf; Rainer Storb; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2006-06

5.  Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

Authors:  Marcelo C Pasquini; Julio Voltarelli; Harold L Atkins; Nelson Hamerschlak; Xiaobo Zhong; Kwang Woo Ahn; Keith M Sullivan; George Carrum; Jeffrey Andrey; Christopher N Bredeson; Mitchell Cairo; Robert Peter Gale; Theresa Hahn; Jan Storek; Mary M Horowitz; Peter A McSweeney; Linda M Griffith; Paolo A Muraro; Steven Z Pavletic; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-13       Impact factor: 5.742

Review 6.  Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.

Authors:  Jacob M van Laar; Kamran Naraghi; Alan Tyndall
Journal:  Rheumatology (Oxford)       Date:  2015-05-06       Impact factor: 7.580

7.  Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.

Authors:  Ola Khorshid; Chitra Hosing; Samer Bibawi; Naoto Ueno; John Reveille; Maureen D Mayes; Richard E Champlin
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

8.  Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Authors:  Dominique Farge; Myriam Labopin; Alan Tyndall; Athanasios Fassas; Gian Luigi Mancardi; Jaap Van Laar; Jian Ouyang; Tomas Kozak; John Moore; Ina Kötter; Virginie Chesnel; Alberto Marmont; Alois Gratwohl; Riccardo Saccardi
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

9.  Predictors of survival in systemic sclerosis (scleroderma).

Authors:  R D Altman; T A Medsger; D A Bloch; B A Michel
Journal:  Arthritis Rheum       Date:  1991-04

10.  Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

Authors:  Jacob M van Laar; Dominique Farge; Jacob K Sont; Kamran Naraghi; Zora Marjanovic; Jérôme Larghero; Annemie J Schuerwegh; Erik W A Marijt; Madelon C Vonk; Anton V Schattenberg; Marco Matucci-Cerinic; Alexandre E Voskuyl; Arjan A van de Loosdrecht; Thomas Daikeler; Ina Kötter; Marc Schmalzing; Thierry Martin; Bruno Lioure; Stefan M Weiner; Alexander Kreuter; Christophe Deligny; Jean-Marc Durand; Paul Emery; Klaus P Machold; Francoise Sarrot-Reynauld; Klaus Warnatz; Daniel F P Adoue; Joël Constans; Hans-Peter Tony; Nicoletta Del Papa; Athanasios Fassas; Andrea Himsel; David Launay; Andrea Lo Monaco; Pierre Philippe; Isabelle Quéré; Éric Rich; Rene Westhovens; Bridget Griffiths; Riccardo Saccardi; Frank H van den Hoogen; Willem E Fibbe; Gérard Socié; Alois Gratwohl; Alan Tyndall
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.